Amphastar Pharmaceuticals Inc. (AMPH) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Amphastar Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Amphastar Pharmaceuticals Inc. (AMPH) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $1.1B. It trades at $26.33, up 2.97% today, at 14.2 times earnings. Its overall quality score is 58 out of 100, ranked against the whole US market. 5 analysts' average target of $22.17 implies −15.8% from today's price. Kronos AI's 30-day forecast is −15.4% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $22.17 |
| Low – high | $20.00 – $30.00 |
| Analysts | 5 |
| Upside to average | −15.8% |
Kronos AI 30-day forecast
| Expected close | $21.64 (−15.4%) |
| Likely range | −24.8% … −10.5% |
| As of | 2026-10-27 |
Quality scores
| Profitability | 73 |
| Solvency | 42 |
| Growth | 58 |
| Overall | 58 |
| P/E | 14.2 |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Halal Health Care stocks · Zakat calculator · Purification calculator